TrialThe Lancet. Neurology2011

Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial.

Davide Pareyson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.